EWS
Eagle Wealth Strategies’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $234K | Buy |
2,818
+37
| +1% | +$3.07K | 0.13% | 86 |
|
|
2025
Q1 | $226K | Sell |
2,781
-173
| -6% | -$14K | 0.14% | 82 |
|
|
2024
Q4 | $266K | Sell |
2,954
-1,089
| -27% | -$98.1K | 0.19% | 82 |
|
|
2024
Q3 | $399K | Sell |
4,043
-1,404
| -26% | -$139K | 0.29% | 53 |
|
|
2024
Q2 | $505K | Buy |
5,447
+216
| +4% | +$20K | 0.41% | 33 |
|
|
2024
Q1 | $491K | Sell |
5,231
-32
| -0.6% | -$3K | 0.4% | 36 |
|
|
2023
Q4 | $470K | Buy |
+5,263
| New | +$470K | 0.28% | 40 |
|